MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$23,331K
EPS
-$0.97
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
22,186
20,320
22,954*
15,050
Research and development - related party
150
150
150*
150
General and administrative
2,267
1,969
3,196*
3,183
Total operating expenses
24,603
22,439
26,299
18,383
Loss from operations
-24,603
-22,439
-26,299*
-18,383
Interest income
-
-
679*
-
Other income, net
1,465
676
-99*
701
Total other income, net
-
-
580*
-
Net loss before taxes
-23,138
-21,763
-25,719*
-
Income tax expense
193
373
259*
-
Net loss
-23,331
-22,136
-25,978
-17,682
Basic EPS
-0.97
-1.24
-1.178*
-0.99
Diluted EPS
-0.97
-1.24
-1.178*
-0.99
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$23,331K
(-107.41%↓ Y/Y)
Net loss before
taxes
-$23,138K
Income tax expense
$193K
Other income, net
$1,465K
(343.94%↑ Y/Y)
Loss from operations
-$24,603K
(-112.48%↓ Y/Y)
Total operating
expenses
$24,603K
(112.48%↑ Y/Y)
Research and development
$22,186K
(161.97%↑ Y/Y)
General and
administrative
$2,267K
(-23.41%↓ Y/Y)
Research and development
- related party
$150K
(0.00%↑ Y/Y)
Buy us a coffee
Forte Biosciences, Inc. (FBRX)
Forte Biosciences, Inc. (FBRX)